239 related articles for article (PubMed ID: 16820585)
1. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury.
Shimamoto A; Chong AJ; Yada M; Shomura S; Takayama H; Fleisig AJ; Agnew ML; Hampton CR; Rothnie CL; Spring DJ; Pohlman TH; Shimpo H; Verrier ED
Circulation; 2006 Jul; 114(1 Suppl):I270-4. PubMed ID: 16820585
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of Toll-like receptor 4 inhibitor eritoran on renal ischemia-reperfusion injury.
Liu M; Gu M; Xu D; Lv Q; Zhang W; Wu Y
Transplant Proc; 2010 Jun; 42(5):1539-44. PubMed ID: 20620471
[TBL] [Abstract][Full Text] [Related]
3. Eritoran attenuates tissue damage and inflammation in hemorrhagic shock/trauma.
Korff S; Loughran P; Cai C; Lee YS; Scott M; Billiar TR
J Surg Res; 2013 Oct; 184(2):e17-25. PubMed ID: 23777984
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling.
Mcdonald KA; Huang H; Tohme S; Loughran P; Ferrero K; Billiar T; Tsung A
Mol Med; 2015 Mar; 20(1):639-48. PubMed ID: 25375408
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart.
Chong AJ; Shimamoto A; Hampton CR; Takayama H; Spring DJ; Rothnie CL; Yada M; Pohlman TH; Verrier ED
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):170-9. PubMed ID: 15282452
[TBL] [Abstract][Full Text] [Related]
6. FR167653 diminishes infarct size in a murine model of myocardial ischemia-reperfusion injury.
Yada M; Shimamoto A; Hampton CR; Chong AJ; Takayama H; Rothnie CL; Spring DJ; Shimpo H; Yada I; Pohlman TH; Verrier ED
J Thorac Cardiovasc Surg; 2004 Oct; 128(4):588-94. PubMed ID: 15457160
[TBL] [Abstract][Full Text] [Related]
7. The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy.
Ehrentraut H; Weber C; Ehrentraut S; Schwederski M; Boehm O; Knuefermann P; Meyer R; Baumgarten G
Eur J Heart Fail; 2011 Jun; 13(6):602-10. PubMed ID: 21613426
[TBL] [Abstract][Full Text] [Related]
8. The TLR4 antagonist Eritoran protects mice from lethal influenza infection.
Shirey KA; Lai W; Scott AJ; Lipsky M; Mistry P; Pletneva LM; Karp CL; McAlees J; Gioannini TL; Weiss J; Chen WH; Ernst RK; Rossignol DP; Gusovsky F; Blanco JC; Vogel SN
Nature; 2013 May; 497(7450):498-502. PubMed ID: 23636320
[TBL] [Abstract][Full Text] [Related]
9. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
[TBL] [Abstract][Full Text] [Related]
10. Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver Injury.
Hsieh YC; Lee KC; Wu PS; Huo TI; Huang YH; Hou MC; Lin HC
Cells; 2021 Jun; 10(6):. PubMed ID: 34205789
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of lipopolysaccharide-induced blood pressure attenuation and vascular contractility.
Ehrentraut S; Frede S; Stapel H; Mengden T; Grohé C; Fandrey J; Meyer R; Baumgarten G
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2170-6. PubMed ID: 17656666
[TBL] [Abstract][Full Text] [Related]
12. The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis.
Ding HS; Yang J; Chen P; Yang J; Bo SQ; Ding JW; Yu QQ
Gene; 2013 Sep; 527(1):389-93. PubMed ID: 23727604
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4/nuclear factor-kappa B pathway is involved in myocardial injury in a rat chronic stress model.
Wang RP; Yao Q; Xiao YB; Zhu SB; Yang L; Feng JM; Li DZ; Li XL; Wu JJ; Chen J
Stress; 2011 Sep; 14(5):567-75. PubMed ID: 21675862
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
[TBL] [Abstract][Full Text] [Related]
15. The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge.
Younan P; Ramanathan P; Graber J; Gusovsky F; Bukreyev A
mBio; 2017 Apr; 8(2):. PubMed ID: 28442605
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway.
Zhang JJ; Peng K; Zhang J; Meng XW; Ji FH
PLoS One; 2017; 12(2):e0172006. PubMed ID: 28222157
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated Virus 9-mediated Small RNA Interference of TLR4 Alleviates Myocardial Ischemia and Reperfusion Injury by Inhibition of the NF-κB and MAPK Signaling Pathways in Rats.
Xu T; Zhang K; Kan F; Li F; Yu B; Du W; Nie H
Curr Mol Med; 2019; 19(2):127-135. PubMed ID: 30854968
[TBL] [Abstract][Full Text] [Related]
18. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion.
Tsung A; Sahai R; Tanaka H; Nakao A; Fink MP; Lotze MT; Yang H; Li J; Tracey KJ; Geller DA; Billiar TR
J Exp Med; 2005 Apr; 201(7):1135-43. PubMed ID: 15795240
[TBL] [Abstract][Full Text] [Related]
19. Effect of the Toll-like receptor 4 antagonist eritoran on retinochoroidal inflammatory damage in a rat model of endotoxin-induced inflammation.
Ekici F; Karaca EE; Korkmaz S; Yüksel O; Gülbahar Ö; Alper M; Ercan S; Or M
Mediators Inflamm; 2014; 2014():643525. PubMed ID: 25165412
[TBL] [Abstract][Full Text] [Related]
20. In vivo Toll-like receptor 4 antagonism restores cardiac function during endotoxemia.
Ehrentraut S; Lohner R; Schwederski M; Ehrentraut H; Boehm O; Noga S; Langhoff P; Baumgarten G; Meyer R; Knuefermann P
Shock; 2011 Dec; 36(6):613-20. PubMed ID: 22089127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
